Together with Antleron, Tuatara Diagnostics embarks on an exciting venture to enhance healthcare and personalized medicine. In the coming 2 years, we will cooperate to develop a Rapid Diagnostic Test and accompanying ‘Point-of-Need‘ device to determine DNA mutations in patients. The results assists healthcare providers to prescribe tailor-made prescription.
Want to know more? You can read all about it in this news post of Interreg CrossRoads Flanders-Netherlands!
